Literature DB >> 15567913

Innate immunity contributes to cochlear adaptive immune responses.

Shigehisa Hashimoto1, Peter Billings, Jeffrey P Harris, Gary S Firestein, Elizabeth M Keithley.   

Abstract

Inner ear immune responses mediated by antigen-specific processes are thought to contribute to hearing loss in humans. Systemic activation of innate immunity contributes to immune responses in the central nervous system. We hypothesized that activation of innate immunity can prime the inner ear for adaptive immune responses and exacerbate disease. Mice were systemically immunized with antigen. Three weeks after initial antigen exposure, the antigen was injected intrathecally coincident with systemic injection of lipopolysaccharide (LPS), an activator of innate immunity. Responses were measured by quantifying the leukocyte infiltrate and cochlear IL-1beta expression. LPS stimulation markedly amplified the adaptive immune response to exogenous antigen in the inner ear. These data indicate that the cochlea is activated by systemic events that stimulate innate immunity and when antigen is present in the inner ear, a robust cochlear adaptive response is generated. If true in humans, this implies that priming may be an important component in the development of immune-mediated hearing loss. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15567913     DOI: 10.1159/000082306

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  29 in total

1.  ERK2-dependent activation of c-Jun is required for nontypeable Haemophilus influenzae-induced CXCL2 upregulation in inner ear fibrocytes.

Authors:  Sejo Oh; Jeong-Im Woo; David J Lim; Sung K Moon
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

2.  IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease.

Authors:  Shresh Pathak; Elliot Goldofsky; Esther X Vivas; Vincent R Bonagura; Andrea Vambutas
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

Review 3.  Immune cells and non-immune cells with immune function in mammalian cochleae.

Authors:  Bo Hua Hu; Celia Zhang; Mitchell D Frye
Journal:  Hear Res       Date:  2017-12-20       Impact factor: 3.208

4.  Acoustic trauma augments the cochlear immune response to antigen.

Authors:  Masumichi Miyao; Gary S Firestein; Elizabeth M Keithley
Journal:  Laryngoscope       Date:  2008-10       Impact factor: 3.325

5.  Systemic immunity influences hearing preservation in cochlear implantation.

Authors:  Melanie Souter; Hayden Eastwood; Paul Marovic; Gordana Kel; Sarin Wongprasartsuk; Allen F Ryan; Stephen John O'Leary
Journal:  Otol Neurotol       Date:  2012-06       Impact factor: 2.311

6.  Audiological findings in pediatric perineal allergic rhinitis (house dust mite allergy) patients.

Authors:  Mustafa Atilla Nursoy; Fadlullah Aksoy; Remzi Dogan; Orhan Ozturan; Sabri Baki Eren; Bayram Veyseller; Emin Ozkaya; Ayşegul Dogan Demir; Burak Ozturk
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-26       Impact factor: 2.503

Review 7.  Allergy and Ménière's disease.

Authors:  M Jennifer Derebery; Karen I Berliner
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

8.  Adenosine and the auditory system.

Authors:  Srdjan M Vlajkovic; Gary D Housley; Peter R Thorne
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

9.  Selective activation of nuclear factor kappa B in the cochlea by sensory and inflammatory stress.

Authors:  J C Adams; B Seed; N Lu; A Landry; R J Xavier
Journal:  Neuroscience       Date:  2009-03-11       Impact factor: 3.590

10.  Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear.

Authors:  Sung K Moon; Jeong-Im Woo; Haa-Yung Lee; Raekil Park; Jun Shimada; Huiqi Pan; Robert Gellibolian; David J Lim
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.